# RETRACTION: Exploring the prophylactic role of soy isoflavones against polycystic ovarian syndrome

## TL;DR

This retracted study claimed soy isoflavones could help prevent polycystic ovarian syndrome, but the findings are unreliable due to issues in the peer review process.

## Contribution

The paper was retracted due to compromised peer review, making its conclusions invalid.

## Key findings

- The peer review process was found to be compromised, leading to the retraction of the article.
- The conclusions about soy isoflavones' prophylactic role are not considered reliable.
- The authors disagreed with the retraction decision.

## Abstract

RETRACTION: Nishaf Manzar, Safwan Ahmad khan, Najum Fatima, Mehr un Nisa, Muhammad Haseeb Ahmad, Muhammad Inam Afzal, Hafiz Fahad Ullah Saeed, Muhammad Imran, Faqir Muhammad Anjum, and Muhammad Sajid Arshad, “Exploring the prophylactic role of soy isoflavones against polycystic ovarian syndrome,” Food Science & Nutrition
9 (2021): 4738–4744. https://doi.org/10.1002/fsn3.2322.

The above article, published online on 09 July 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editor‐in‐Chief, Y. Martin Lo, and Wiley Periodicals, LLC. The retraction has been agreed to following concerns about the peer review process. The editorial office found unambiguous evidence that the manuscript was accepted solely based on compromised and insufficient reviewer reports. This evidence was further investigated and verified by the publisher and the Editor‐in‐Chief. As a result, the conclusions of this article are not considered reliable. The authors were notified of the retraction and disagreed with this decision.